# Relmada Therapeutics, Inc.: Form 8-K, filed Jan 11, 2024

- Company: [Relmada Therapeutics, Inc.](/companies/rlmd.md) (CIK 1553643)
- Form: 8-K
- Filed: 2024-01-11
- Accepted by EDGAR: Jan 11, 2024, 16:30 ET
- Period: 2024-01-05
- Accession: 0001213900-24-003000
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1553643/000121390024003000/ea191520-8k_relmada.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1553643/000121390024003000/

## Items reported

- Item 5.02: Departure or appointment of officers or directors

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1553643/000121390024003000/ea191520-8k_relmada.htm

Filed Jan 11, 2024.
Source: SEC EDGAR, the filing index for accession 0001213900-24-003000. Last ingested by Listed: Oct 24, 2026, 15:13 ET. No prices; not investment advice.